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INTRODUCTION
Nature is a masterful and prolific chemist. The ever-ex-
panding catalog of natural products from plants and mi-
crobes currently stands at more than 100,000 different com-
pounds (58). This collection has profoundly influenced
human well-being. Natural products have been used to treat
pain, infections, and disease for thousands of years; their
equally ancient and diverse uses as colorants, spices, fra-
grances, aphrodisiacs, cosmetics, and toxins have been fun-
damental to human culture and development. This trend
shows no signs of subsiding. Of the 877 new small-molecule
pharmacological entities introduced worldwide between
1981 and 2002, 61% can be traced to natural products (142).
A similar proportion (59%) of the 137 small molecules in
phase II or III clinical trials for cancer treatment (as of June
2003) are natural products or closely related compounds
(172). Natural products and their derivatives therefore re-
main an essential component of the pharmaceutical industry
(172). Given the wealth of functional small molecules in
nature, it is perhaps not surprising that so much effort today
goes into prospecting for new ones or modifying existing
ones. Academic and industrial laboratories, often in massive
screening programs, continue to isolate and characterize
promising new compounds from biological extracts. In ad-
dition, molecular scaffolds inspired by natural products are
increasingly being used as the basis for synthesizing combi-
natorial chemical libraries which can be screened for pro-
tein-binding or other biochemical activities (30).
Although impressive in number, the known products of
natural biosynthetic pathways account for but a tiny fraction
of the structures that could be produced. This essentially
infinite space of possible functional molecules represents an
irresistible frontier for those seeking new, bioactive com-
pounds. For example, only 1/10 of the 877 new small-mole-
cule pharmacological entities mentioned above are bona fide
natural products—most are derivatives of natural products,
synthetic compounds with natural product-derived moieties, or
natural-product mimics (142). The chemical space surrounding
natural products is particularly rich in biologically functional
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molecules, and structurally related compounds can serve hu-
man purposes even better than natural products themselves.
Researchers are now beginning to explore some of these nearly
natural products by mixing, matching, and mutating biosyn-
thetic genes from diverse sources in organisms such as Esche-
richia coli and screening for production of novel metabolites.
In this review we illustrate how pathways can be “evolved”
rapidly in the laboratory to generate new natural products.
Used in this way, directed laboratory evolution is a powerful
tool for discovering new pathways and for in vivo combinato-
rial chemistry of natural products, i.e., “combinatorial biosyn-
thesis.”
In addition to providing access to novel metabolites, labo-
ratory evolution studies can offer insights into the natural evo-
lution of metabolic pathways and their constituent enzymes.
Comparative studies of homologous enzymes can readily iden-
tify similarities such as conserved residues and folds. However,
identifying the exact genetic changes responsible for differ-
ences in the specificity, stability, or other properties of related
enzymes is much more difficult. When comparing sequences
that have diverged over millions of years, it is almost impossi-
ble to distinguish the handful of adaptive mutations from the
plethora of differences that reflect evolutionary drift. In con-
trast, evolution in the laboratory allows us to capture new
metabolic pathways in the act of emerging and permits the
identification and analysis of the molecular events that gave
rise to the new product distributions.
With carotenoid biosynthesis as our model, we describe
how pathway engineers have used laboratory evolution ex-
periments to diversify biosynthetic pathways and what they
have learned from those efforts. This work has demon-
strated the remarkable ability of carotenoid biosynthetic
enzymes to evolve and acquire new specificities and has
illuminated pathway features that facilitate the creation of
new natural products based on “unnatural” molecular scaf-
folds. Although evolutionary pathway engineering is in its
infancy, we show that it is capable of generating whole new
families of natural product analogs. Some of these com-
pounds may await discovery in nature, while others will
probably never be found by natural evolution.
Overview of Carotenoid Biosynthetic Pathways
The carotenoids are a subfamily of the isoprenoids and are
among the most widespread of all natural products. Carote-
noids are responsible for many of the colors of animals, plants,
and microorganisms and play important biological roles as
accessory light-harvesting components of photosynthetic sys-
tems, photoprotecting antioxidants, and regulators of mem-
brane fluidity. As a whole, the natural C30 and C40 carotenoid
biosynthetic pathways can be organized in a tree-like hierarchy
(Fig. 1), with the trunk representing the initial, universal step
of backbone synthesis catalyzed by a carotenoid synthase and
the outward-emanating branches and subbranches collectively
denoting the various downstream modification steps seen in
different species (8). The hundreds of known carotenoid bio-
synthetic enzymes fall into relatively few classes, based on the
types of transformation they catalyze (isoprenyl diphosphate
synthases, carotenoid synthases, desaturases, cyclases, etc.). The
enzymes responsible for various versions of a basic transfor-
mation are related by evolution (111, 163, 176): the pathways
diverged on accumulation of mutations that altered enzyme
specificity. Thus, a small number of basic transformations, sub-
tly modified in different species, collectively lead to a large
number of different products, although only a handful of caro-
tenoids (usually a few and almost always fewer than 10) are
made by any one organism.
C40 carotenoids are made in thousands of plant and mi-
crobial species, starting with the synthase-catalyzed conden-
sation of two molecules of geranylgeranyl diphosphate
(C20PP) to form phytoene (Fig. 1). (Most phytoene syn-
thases produce the 15Z isomer of phytoene [87].) Different
types and levels of modification of this C40 backbone ac-
count for the majority of known carotenoids. C30 carotenoid
pathways starting with the condensation of two molecules of
farnesyl diphosphate (C15PP) to form (15Z)-4,4-diapophy-
toene (also called dehy-drosqualene) are much less wide-
spread, having been found only in a small number of bac-
teria such as Staphylococcus, Streptococcus, Heliobacterium,
and Methylobacterium species (55, 100, 101, 129, 130, 198,
205, 206). These initial C30 and C40 condensation products are
dehydrogenated in a stepwise manner by desaturase enzymes,
which represent the next important branch points for pathway
diversification (70). In bacteria and fungi, a single desaturase
catalyzes the entire sequence of carotenoid desaturation steps
(32). Carotenoid desaturation in plants, algae, and cyanobac-
teria (not covered in this review) is accomplished by two dis-
tinct desaturases and a carotenoid isomerase (7, 31, 72, 86,
131). Desaturases from bacteria such as Pantoea spp. (referred
to in this review by their former Erwinia species names, which
are more commonly used than the current approved names in
the carotenoid field) also catalyze isomerization of the carote-
noid’s central double bond, giving all-E (trans) desaturated
products (65). With a few notable exceptions (157, 200), the
desaturation level of the carotenoid backbone is well defined
for each organism. In many organisms, desaturation is followed
by cyclization, catalyzed by a - or ε-cyclase and leading to
carotenoids with one or two cyclized ends. A variety of further
enzyme-catalyzed transformations that can include ketolation,
hydroxylation, glycosylation, and oxidative cleavage act on sub-
strates derived from the C30 or C40 backbones to produce the
catalog of more than 700 known carotenoids (82).
Some organisms synthesize modified C40 carotenoids with
additional or fewer isoprenyl units. For example, Corynebacte-
rium glutamicum synthesizes “homocarotenoids” such as flavu-
xanthin (C45) and decaprenoxanthin (C50) via enzymatic pre-
nylation of lycopene (Fig. 1) (109, 112). In contrast, several
fungi produce C35 “apocarotenoids” such as neurosporaxan-
thin via oxidative cleavage of monocyclic C40 carotenoids (Fig.
1) (12, 14, 164, 215). Despite their non-C40 structures, these
natural homo- and apocarotenoids are, from a biosynthetic per-
spective, part of the C40 family, since their biosynthesis pro-
ceeds via the C40 carotenoid backbone phytoene.
Isoprenoids and isoprenyl diphosphate building blocks
are found in all organisms. E. coli has three isoprenyl
diphosphate synthases: a farnesyl diphosphate (C15PP) syn-
thase (67, 68), an octaprenyl diphosphate (C40PP) synthase
(154), and a Z-type (see below) undecaprenyl diphosphate
(C55PP) synthase (94). A C30 carotenoid pathway can be
built in E. coli branching directly from the organism’s en-
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dogenous C15PP supply (226). However, since E. coli lacks a
C20PP synthase function, a geranylgeranyl diphosphate
(C20PP) synthase gene must be heterologously expressed
along with the other carotenoid biosynthetic genes in order
to make C40 carotenoids in this organism.
Most of the enzymes involved in carotenoid biosynthesis are
membrane associated, and the hydrophobic intermediates and
products of carotenoid pathways partition to cytoplasmic or
organelle membranes, depending on the type of organism (29).
It is not known whether the carotenoid biosynthetic enzymes
associate into complexes. Over the years, evidence for the
existence of multienzyme complexes that function as assembly
lines for carotenoid synthesis has been presented (summarized
in reference 32). Some of the most convincing evidence has
come from experiments performed in the laboratory of Cerda´-
Olmedo with the fungus Phycomyces blakesleeanus (6, 39, 57,
138). On the other hand, the fact that carotenoid enzymes from
different organisms are readily combined to generate func-
tional pathways in heterologous hosts is evidence that the for-
mation of a specific enzyme complex is not a prerequisite for
carotenoid biosynthesis. Throughout this review, we refer to
carotenoid-synthesizing enzyme complexes when they provide
a possible alternative explanation for particular observations
from our laboratory and others’.
FIG. 1. Natural carotenoid biosynthetic pathways can be organized in a tree-like hierarchy. The biosynthesis of all natural carotenoids begins
with the enzymatic assembly of a C30 or C40 backbone. These backbones are desaturated, cyclized, oxidized, and otherwise modified by downstream
enzymes in various species-specific combinations. Shown are several common types of enzymatic transformations that occur in natural carotenoid
pathways. Common carotenoids formed early in a pathway, such as lycopene, are modified in different organisms depending on the enzymes
present. The multiple enzymatic routes originating from intermediates common to many end products result in extensive pathway branching (and
subbranching).
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Carotenoids as a Model System for Laboratory
Pathway Evolution
Carotenoid biosynthesis is particularly well suited as an ex-
perimental system for studying pathway evolution in the labo-
ratory. Claudia Schmidt-Dannert recognized that the following
features would facilitate such experiments when she first pro-
posed to evolve these pathways as a visiting researcher in this
laboratory in 1998.
Carotenoids are diverse, and their biosynthetic pathways are
representative of other secondary metabolic pathways. Hun-
dreds of carotenoids are known in nature. They are made using
a few basic transformations, the earliest of which are highly
conserved. The reactions involved in these early steps, such as
backbone formation by carotenoid synthases and cyclization by
carotenoid cyclases, are mechanistically similar to other reac-
tions in isoprenoid biosynthesis. Modification steps later in the
carotenoid pathways cover a wide range of biotransformations,
many of which appear in other natural products. Thus, expe-
rience with carotenoid pathway evolution can be applied to
diversifying other biosynthetic pathways.
Carotenoid biosynthetic enzymes are highly portable. The
carotenoid pathway emerges directly from the central isopre-
noid pathway that exists in all organisms. Thus, in principle,
any organism can supply the precursors required for an engi-
neered carotenoid pathway. Carotenoid biosynthetic genes can
be expressed in a wide range of organisms to extend or redirect
an existing pathway (69, 70, 105). For instance, a bacterial phy-
toene desaturase (CrtI) introduced into cyanobacteria (227)
and tobacco plants (136) elevated their resistance to the
herbicide norflurazon (known to block plant-type phytoene
desaturases). Plastid-targeted introduction of an algal ,-car-
otene ketolase resulted in transgenic tobacco plants that accu-
mulated astaxanthin and changed the color of the plant’s nec-
tory tissue from yellow to red (128). The highly publicized
introduction of the ,-carotene pathway into rice resulted in
substantial ,-carotene levels in the normally carotenoid-free
endosperm and therefore greater nutritional value for this
food staple (234). Phytoene-producing human cells (HeLa,
NIH 3T3 etc.) were created by the addition of a bacterial
phytoene synthase and showed increased tolerance to oxidative
shock as well as a lower rate of H-ras-induced carcinogenesis
(143, 144, 179). Almost all carotenoid biosynthetic genes
cloned to date, including those from plants, can be functionally
expressed in E. coli (119, 175, 177, 180), as can animal oxida-
tive cleavage enzymes (98, 123, 158, 220, 231). The “portabil-
ity” of these enzymes greatly facilitates the assembly and evo-
lution of novel biosynthetic pathways.
Evolution of carotenoid pathways can be tracked visually.
Carotenoids are natural pigments, and their characteristic col-
ors are ideal for product-based high-throughput screening. Sci-
entists have made good use of this feature throughout the
history of carotenoid research. Experiments involving the gen-
eration and analysis of mutant strains exhibiting altered colors
have elucidated biosynthetic routes in various organisms (12,
15, 18, 40, 66, 73, 113, 120, 130, 155, 162, 173, 178, 196, 201,
216). Many carotenoid biosynthetic genes were cloned based
on their ability to confer or alter color development in E. coli
(52, 54, 133, 134, 160, 197). Carotenoid titers are an indicator
of precursor levels and can be used to evaluate and tune
upstream (isoprenoid) pathways (189, 223, 224). The colors
generated in E. coli colonies provide a facile screen for new
pathway products in a laboratory evolution experiment.
Carotenoids are valuable in their own right. The polyene
chromophores of carotenoids, which absorb light in the 400 to
550-nm range, provide the basis for their characteristic yellow-
to-red colors and their ability to quench singlet oxygen (5, 74,
79, 95, 103, 137, 218, 230). Carotenoids act as antioxidants in
vivo (170, 183, 210), and many beneficial effects of carotenoids
on human health have been reported, ranging from cancer
prevention and tumor suppression to upregulation of immune
function, reduction of the risk of coronary heart disease or
age-related degeneration, and cataract prevention (19, 21, 42,
47, 83, 108). As natural pigments, carotenoids are used as
colorants in foods, cosmetics, and flowers (117, 128, 209).
Given these diverse and important properties of known caro-
tenoids, we can assume that novel compounds of this family
will also possess interesting biological or chemical functions.
Evolvable Pathways and Enzymes
The diversity of carotenoids and biosynthetic enzymes that
exists in nature demonstrates the success of evolution in dis-
covering and optimizing new pathways. Carotenoid pathways
are evolvable and understanding the features that lead to this
evolvability will allow us to design directed evolution experi-
ments to accomplish the same goals. We define an evolvable
pathway as one which can produce many new metabolites after
limited genetic change. New metabolites are made following
recruitment of new enzymes or functional alteration of existing
ones. Such events are rare, and evolvable pathways must be
particularly effective at exploiting these rare events.
In general, evolvable pathways appear to contain enzymes
that are “locally specific” (32). These enzymes are not un-
specific; rather, they recognize a particular structural motif
common to a variety of possible substrates. Thus, if a change
upstream of a locally specific enzyme generates a novel com-
pound, there is a good chance that the enzyme will metabolize
this compound further (as long as it retains the required motif)
and generate a new derivative. More such enzymes further
downstream will accept the new derivative(s) and produce yet
more new metabolites. A carotenoid desaturase, for example,
might need at most a few mutations in order to catalyze dou-
ble-bond formation on a new carotenoid-like backbone. Lo-
cally specific modifying enzymes further downstream would,
with high probability, accept these desaturated substrates, gen-
erating still more new compounds.
Pathway structure also contributes to evolvability: highly
branched pathways can propagate discoveries along many
routes. Pathway branches occur where one substrate is poten-
tially converted to multiple products by the action of one or
more enzymes. The existence of nested branches geometrically
increases the number of new products that can be synthesized
from a new metabolite produced upstream, provided that the
downstream enzymes accept the new substrates. Evolvable and
consequently diverse, carotenoid pathways are “bushy,” with
multiple products possible from each basic transformation.
Product possibilities are dictated by the nature of the chemical
reaction and substrate and ultimately by the specificity of the
enzyme that controls that branch point. For example, desatu-
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ration of a carotenoid backbone can produce a number of
different products—the one(s) produced by any given organ-
ism reflect the specificity of its particular desaturase in its
environment. That specificity can change upon mutation and
can open new pathway branches.
Pathways constructed entirely of locally specific enzymes
would not serve a host organism well in terms of regulation
and production of tried-and-true metabolites. Thus, we expect
evolvable pathways to contain more specific enzymes as well.
To maximize the ease of exploring new pathways while pre-
serving key metabolic processes, we would expect these specific
enzymes to be located at the earliest steps of a pathway. Here,
they can serve as molecular gatekeepers, allowing only certain
primary metabolites to enter but not impeding the discovery of
new structures within the pathway. Manipulating these gate-
keeper enzymes to admit different substrates should be an ef-
fective way to generate whole new families of natural products.
Thus, features contributing to the evolvability of a biosyn-
thetic pathway include the use of locally specific enzymes and
biotransformations that contribute to pathway branching. More-
specific gatekeeper enzymes limit what flows through the path-
way, providing necessary insurance against chemical chaos. In
the end, however, pathways are evolvable because their com-
ponent enzymes are themselves evolvable, changing properties
such as substrate and product specificity readily on mutation.
Evolvable enzymes should also exhibit multiple mutational
routes to a given altered phenotype and may be comparatively
robust to mutation. The former property increases the chances
that new phenotypes will emerge, while the latter property
allows “scanning” of similar sequences without loss of function.
Perhaps surprisingly, it is still an open question whether pro-
miscuous or locally specific enzymes are more evolvable than
enzymes that are highly specific. As we detail in this review, as
little as a single amino acid substitution can change the spec-
ificity of highly specific carotenoid biosynthetic enzymes.
An evolvable pathway, then, would consist of an evolvable
gatekeeper enzyme (or set of enzymes) coupled with locally spe-
cific downstream enzymes. Such an arrangement maximally
exploits mutations in the gatekeeper enzyme, converting a sin-
gle newly discovered molecule into a potentially large number
of new metabolites. Several lines of evidence support the view
that the enzymes involved in carotenoid biosynthesis are highly
evolvable and are embedded in pathways with such evolvable
structures. This review represents the first attempt at gathering
together this evidence, which collectively paints a picture of
carotenoid biosynthetic pathways as dynamic systems capable
of exploring a diversity of product structures much greater than
is seen in nature. We now examine the various ways in which
this evolvability has been exploited in the laboratory to explore
and extend the product diversity of these pathways.
APPROACHES TO ENGINEERING NOVEL
BIOSYNTHETIC PATHWAYS
New biosynthetic pathways can be created by recruiting for-
eign catalytic machinery that adds a new branch; such enzyme
recruitment happened frequently during the evolution of nat-
ural-product pathways (20, 27, 116). A pathway can also diver-
sify when the function of an existing enzyme is altered by
mutation or other genetic change. The wide functional diver-
sity that exists within the evolutionarily related carotenoid
pathways is evidence that enzyme evolution has played a cen-
tral role in creating chemical diversity, primarily through mod-
ification of substrate and product specificity. In the laboratory,
researchers can now employ the same strategies of enzyme
recruitment and modification to create new biosynthetic path-
ways. In this review, we refer to coexpressing genes from dif-
ferent sources in a recombinant organism as gene assembly.
This approach can be distinguished from directed evolution of
the component enzymes (or their regulation), where libraries
of mutant alleles are expressed along with other pathway genes
in host cells, which are then screened or selected for desired
properties. These two approaches generate novel compounds
by mimicking the major modes of natural pathway evolution:
gene transfer and divergence. Thus, the two approaches com-
plement one another, and we consider both to fall under the
umbrella of laboratory pathway evolution. In this section, we
discuss efforts to create new carotenoid biosynthetic pathways
by using gene assembly, directed enzyme evolution, and com-
bined approaches.
Engineering Pathways by Gene Assembly
Assembling carotenoid biosynthetic genes from different or-
ganisms and expressing these “hybrid” pathways in a recombi-
nant host has generated functional routes to rare or novel
carotenoids (Fig. 2) (4, 5, 13, 69, 105, 118, 192, 199, 211).
Where gene assembly alone successfully yielded a new pathway
branch or extension, the recruited enzyme(s) usually catalyzed
transformations later in the pathway. These downstream en-
zymes are locally specific and can accept a range of substrates.
Various unusual acyclic carotenoids were obtained by assem-
bling carotenogenic genes from Pantoea ananatis (Erwinia ure-
dovora) and Rhodobacter capsulatus (4, 5). Coexpression of the
C20PP synthase CrtE and the phytoene synthase CrtB from
E. uredovora along with various combinations of three different
carotenoid desaturases, a carotenoid hydratase, a -cyclase,
and a hydroxylase resulted in the production of four previously
unidentified carotenoids, including 1-OH-3,4-didehydrolyco-
pene with potent antioxidant activity (5). In another example,
addition of CrtW, a -end ketolase from Paracoccus sp. strain
MBIC1143 (“Agrobacterium aurantiacum”), extended the zea-
xanthin -D-diglucoside pathway from Erwinia, leading to syn-
thesis of novel compounds astaxanthin -D-diglucoside and
adonixanthin 3--D-glucoside (Figure 2) (235). As we show
in later sections, other downstream carotenoid-modifying en-
zymes are also locally specific and should be similarly useful for
“combinatorial biosynthesis” of novel carotenoids by gene as-
sembly. We predict that systematic combinatorial assembly of
these genes will result in the biosynthesis of many hundreds of
new carotenoids.
Assembling locally specific enzymes in a recombinant organ-
ism can sometimes result in an interconnected “matrix” path-
way that leads to numerous carotenoid structures, as illustrated
in Fig. 3 (135). However, many of the intermediates or end
products may not be accessible due to imbalances in enzyme
expression, activity, or specificity. Thus, a few dominant com-
pounds may be produced, while other (possible) ones remain
hidden (but poised to appear under different conditions). Fur-
thermore, it can be difficult to predict the relative abundances
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of the different metabolites. For example, various attempts to
construct a pathway for astaxanthin synthesis in a heterologous
host resulted in quite different proportions of astaxanthin and
intermediates (76, 135). In another example, introduction of the
carotenoid biosynthetic enzymes CrtB, CrtI, CrtY, and CrtZ
from Pantoea agglomerans (Erwinia herbicola) into a desaturase-
deleted mutant of Rhodobacter sphaeroides merely restored
desaturation activity and failed to alter the range of carote-
noids produced (85). This occurred despite the introduction of
a -cyclase (CrtY) and a -end hydroxylase (CrtZ) into a host
lacking these catalytic functions. Only when the endogenous
neurosporene hydroxylase gene (crtC) was deleted was a func-
tional pathway to cyclized and hydroxylated carotenoids real-
ized (69, 70). In this case, the endogenous CrtC in R. sphaer-
FIG. 2. Selected examples of gene assembly leading to novel carotenoids in E. coli. Combining enzymes from different source organisms can
lead to rare or novel carotenoids. In some cases, such as with CrtC and CrtD (4, 5), new pathway branches can be uncovered by replacing an enzyme
with its counterpart from a different organism (192). Carotenoids in boxes had not been previously identified in biological material or chemically
synthesized. Enzyme abbreviations: Al-1, phytoene desaturase from Neurospora crassa (five-step); CrtC, neurosporene 1,2-hydratase; CrtD, 1-OH-
neurosporene 3,4-desaturase; CrtIEu, phytoene desaturase from Erwinia uredovora (four-step); CrtIRc, phytoene desaturase from Rhodobacter
capsulatus (three-step); CrtW, ,-carotene 4,(4)-ketolase; CrtX, zeaxanthin glycosylase; CrtY, lycopene -cyclase; CrtZ, ,-carotene 3,(3)-
hydroxylase. Other enzyme subscripts: Aa, “Agrobacterium aurantiacum” (current designation, Paracoccus sp. strain MBIC1143); Eu, Erwinia
uredovora (current approved name, Pantoea ananatis); Rg, Rubrivivax gelatinosus; Rs, Rhodobacter sphaeroides. Natural pathways leading to the
synthesis of demethylspheroidene and ,-carotene are shaded. The dotted arrow represents trace enzymatic conversion, and the crossed-out
arrow denotes undetectable enzymatic conversion. References to original publications describing the biosynthesis of various compounds are given
in brackets beside compound names.
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oides may have been so active that the desaturase CrtI, cyclase
CrtY, and -end hydroxylase CrtZ introduced from E. herbi-
cola could not compete with it for neurosporene. Another
possible explanation is that incorporation of CrtC into a ca-
rotenoid biosynthetic enzyme complex blocked the additional
inclusion of CrtY, CrtZ, and more than three desaturase sub-
units. These examples illustrate the importance of properly
coordinating pathway enzymes in order to create a specific
pathway to a desired product. This problem of miscoordination
makes it exceedingly difficult to systematically explore all the
possible metabolites of a given set of enzymes solely by gene
assembly. A major task of pathway engineers will be to coor-
dinate assembled components in order to unmask hidden me-
tabolites. This can be accomplished by directed evolution.
Engineering Pathways by Directed Enzyme Evolution
Nature has generated a vast number of biosynthetic genes by
mutation, recombination, and natural selection. Variations in
properties such as desaturation step number or synthase spec-
ificity contribute enormously to the diversity of carotenoid
structures seen in nature. In the previous section, we presented
examples of how gene assembly alone can lead to novel or
unusual carotenoids. However, we can also consider creating
enzyme variants with desired specificities (or other properties
such as expression level or stability) by evolving them in the
laboratory. This approach circumvents the need to find a spe-
cific function in nature and reproduce that function in a het-
erologous host. Instead, enzymes with the desired properties
are found by screening libraries of mutants of an enzyme that
performs the same type of chemical transformation.
Some enzyme specificities not available in nature become
readily available by evolution in the laboratory, opening path-
ways to new metabolites. Decoupled from the biological con-
straints imposed by the need to fulfill a particular function
throughout the course of evolution, a pathway can in principle
explore all chemically accessible products, not just those that
are biologically relevant (10). Thus, directed evolution gives us
the ability to explore the space of possible chemical products
much more rapidly and also more thoroughly than does natural
evolution. By evolving biosynthetic enzymes, we can anticipate
the discovery of large numbers of new natural products on the
benchtop in convenient laboratory hosts.
Although each directed evolution project is unique, all in-
volve two main steps: making a library of mutants and search-
ing that library for desired properties. The mutant library is
typically generated in an error-prone PCR amplification (38,
124) tuned to generate a certain average point mutation rate or
FIG. 3. “Matrix” pathway resulting from the coexpression of carotenoid biosynthetic enzymes with broad specificity. Coexpression in E. coli of
CrtW [,-carotene 4,(4)-ketolase] and CrtZ [,-carotene 3,(3)-hydroxylase] from “Agrobacterium aurantiacum” (current designation, Para-
coccus sp. strain MBIC1143) along with the genes for ,-carotene synthesis from E. uredovora (current approved name, Pantoea ananatis) resulted
in the biosynthesis of at least nine different ,-carotene derivatives (135). This figure was made using data from reference 135.
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by DNA shuffling, a method that makes new point mutations
and recombines existing mutations (193) (many methods are
available for making libraries of mutant genes for directed
evolution; useful protocols are given in reference 9). The li-
brary of mutated DNA molecules is then subcloned into an
appropriate vector for expression with other pathway genes in
a convenient host organism such as E. coli. Hundreds or thou-
sands of clones are screened in search of (typically) rare ones
expressing favorably altered enzymes. A powerful aspect of this
process is that it can be iterated—improved variants can be
subjected to further rounds of mutagenesis and screening,
often leading to further improvements. A sensitive, reliable
screen is key to a successful directed evolution experiment: the
screen allows the researcher to identify the typically rare mu-
tants with new and interesting properties.
Different strategies exist for evolving metabolic pathways in
the laboratory. In an early study, multiple genes in an arsenate
degradation pathway were subjected to mutagenesis and
recombination all at once (49). This “fully blind” approach
makes the most sense when little is known about which genes
or noncoding regions (such as ribosomal binding sites) should
be mutated to obtain a desired phenotype. However, a signif-
icant disadvantage of this approach is that the combinatorial
complexity (the size of the library) increases concomitantly
with the length of DNA targeted for mutation. Consequently,
more clones must be screened to find the rare ones with im-
proved properties. Therefore, when possible, it is attractive to
target individual genes for mutation and then screen those
mutants in the context of the whole pathway; this can be
thought of as a “partially blind” approach. Carotenoid biosyn-
thetic pathways are sufficiently well characterized that investi-
gators generally know which enzyme to target for mutagene-
sis in order to achieve a new product distribution; however,
the specific mutation(s) needed is unknown. Accordingly,
researchers have thus far chosen to extend carotenoid pathway
branches in a stepwise manner by evolving one gene at a time
and expressing the library of variant alleles together with other
wild-type or previously laboratory-evolved pathway genes.
Schmidt-Dannert et al. demonstrated the effectiveness of this
approach for diversifying the range of carotenoid structures
accessible from a given set of enzymes (181).
PROBING THE EVOLVABILITY OF CAROTENOID
BIOSYNTHETIC ENZYMES AND PATHWAYS
In the Introduction, we reasoned that highly evolvable path-
ways would be assembled from locally specific downstream
enzymes and (a small number of) more specific “gatekeeper”
enzymes. Furthermore, the enzymes themselves should readily
alter specificity on mutation. Modifying a gatekeeper enzyme,
accompanied by fine-tuning of downstream enzymes where
needed, could allow whole new families of natural products to
emerge. In this section, we assess the evolvability of carotenoid
biosynthetic pathways and enzymes in view of the (laboratory)
data now available.
Directed Evolution of Key Carotenoid Biosynthetic Enzymes
Isoprenyl diphosphate synthases. Isoprenyl diphosphate
synthases (IDSs) catalyze the consecutive condensation of five-
carbon isopentenyl diphosphate with allylic diphosphates to
generate the precursors to all isoprenoid compounds. A variety
of IDSs supply the building blocks for the 23,000 known
isoprenoids ranging in size from C5 to C2,500 (48, 146). IDSs
catalyze the 1–4 condensation of an allylic diphosphate
(C5nPP) with isopentenyl diphosphate, producing the next in-
cremental isoprenyl diphosphate (C5(n  1)PP) (Fig. 4). This
process continues until the growing isoprenoid chain reaches a
certain length, at which point the reaction terminates and the
product is released from the enzyme. There exist E-type IDSs
that synthesize products with precise all-E (trans) double-bond
stereochemistry as well as Z-type IDSs that catalyze the for-
mation of cis-double bonds in the growing isoprenyl chain. IDS
enzymes are quite specific in their product size and are often
classified on this basis. Elucidating the molecular mechanisms
of chain length control has been a major scientific interest in
the study of this class of enzymes; for reviews, see references
97, 122, 145, and 225.
Although IDSs make specific products, minor modifications
can change this specificity. Ohnuma et al. randomly mutated
the farnesyl diphosphate (C15PP) synthase gene from Bacillus
stearothermophilus (bstFPS), coexpressed this mutant library
along with phytoene synthase (crtB) and phytoene desaturase
(crtI) genes in E. coli, and looked for colonies that produced
the red C40 carotenoid, lycopene (152). Most of the colonies
were colorless because they lacked the C20PP precursor need-
ed by CrtB to make carotenoids. However, a small fraction of
the colonies were pink due to lycopene production; these har-
bored mutant C15PP synthases capable of synthesizing C20PP.
In further work, the same group generated additional variants
of BstFPS that made even longer products (150). Some of the
double and triple mutants of this enzyme yielded products as
large as C100PP. In another study, Ohnuma et al. converted
an archaebacterial C20PP synthase into C25PP and C30PP syn-
thases by mutagenesis coupled with complementation screen-
ing in a yeast strain deficient in C30PP synthesis (148). In all the
above cases, analysis of mutants making larger products re-
vealed substitutions for smaller amino acids at a position 5
residues upstream of the first aspartate-rich motif (FARM) of
the enzyme (151). Aided by the crystal structure of Gallus
gallus (chicken) C15PP synthase (204), Tarshis et al. indepen-
dently found a similar result with this enzyme (203). Site-
directed mutagenesis at the fifth (F112) and fourth (F113)
residues upstream of the FARM showed that smaller amino
acids at these positions yielded enzymes that produce longer
products. Subsequent work also demonstrated the converse:
replacement of chain-length determining residues upstream of
but close to the FARM with larger amino acids leads to shorter
products. For example, Sulfolobus acidocaldarius C20PP syn-
thase was rationally converted into a C15PP synthase by using
this approach (149). The C15PP synthases from B. stearother-
mophilus and G. gallus were converted to geranyl diphosphate
(C10PP) synthases by the same strategy (61, 141).
This strategy of substituting residues just upstream of the
FARM with smaller or larger amino acids has also been ap-
plied to a plant short-chain (C20PP) IDS (104), heterodimeric
medium-chain (C30PP and C35PP) IDSs (78, 81, 238), as well as
long-chain (C40PP-C50PP) synthases (75, 153) to alter the prod-
uct chain length. In several cases, substitution of residues lining
the substrate binding pocket but distant from the FARM (or
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FIG. 4. Chain elongation reactions catalyzed by natural all-E IDSs. Each IDS adds a defined number of IPP molecules to an allylic diphosphate
substrate before the final product is released. Wild-type IDSs have quite stringent product specificity; catalytic ranges of known all-E IDSs are
shown with arrows on the right. Natural products derived from the various isoprenyl diphosphates are shown on the left. This figure was made using
data from reference 225.
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even located on the opposite subunit in heterodimeric en-
zymes) has also modified the product chain length (75, 77, 80,
92, 96, 148, 152, 238, 239). Many of these substitutions enhance
the effects of mutations upstream of the FARM, leading to
even greater changes in the product chain length.
Several C15PP synthases have some degree of substrate tol-
erance (56, 107) and can be used for stereospecific synthesis of
various insect hormones and related analogs (102, 106, 126).
BstFPS was found to accept a number of nonnatural substrates
(140), and its substrate range was further broadened by sub-
stitutions at Y81, previously described as a chain length-deter-
mining residue (151) (see above). The Y81A variant of BstFPS,
for example, accepts various isoprenyl diphosphate analogs
with -oxygen atoms in their prenyl chains as substrates, lead-
ing to the enzymatic synthesis of butterfly hair pencil phero-
mone and analogs (125). In theory, all of these isoprenoid
diphosphate analogs could serve as building blocks for the
enzymatic synthesis of carotenoid analogs.
IDSs from diverse species have exhibited evolvability in the
laboratory. Although the wild-type IDSs are quite specific with
respect to product size, minor genetic changes were found to
profoundly alter the number of elongation steps and therefore
the size of the products formed by these enzymes. The residues
that were found to change the specificity of these IDSs upon
mutation form a key part of the reaction pocket that accom-
modates the elongating isoprenoid chain, and it appears that
product specificity is largely dependent on the size of this
pocket (61, 203). Inspection of the data from the reports de-
scribing the modification of product specificity reveals that,
in general, the mutant IDSs have a broadened rather than a
shifted product range. In most cases, mutants synthesize mul-
tiple new products as well as the old one. In contrast, wild-type
IDSs, although related by evolution, are very specific with
respect to the length of their products. We now know that a
single amino acid substitution can broaden the product range
of an IDS. However, we do not know the degree of genetic
change required to completely shift IDS product specificity
such that it synthesizes only isoprenyl diphosphates of a new
length.
Carotenoid synthases. Carotenoid synthases catalyze the
synthesis of a carotenoid backbone from isoprenyl diphosphate
precursors. Various phytoene (C40) synthases have been iso-
lated from organisms ranging from bacteria to higher plants.
Only one C30 carotenoid synthase has been cloned and se-
quenced to date: crtM from Staphylococcus aureus (226).
It has long been recognized that the enzyme-catalyzed reac-
tion leading to formation of the carotenoid backbone is very
similar to the reaction catalyzed by squalene synthase (SqS),
the first committed enzyme in cholesterol biosynthesis (32).
Carotenoid synthases and SqS employ the same mechanism,
and SqS produces the C30 carotenoid backbone if deprived of
NADPH (88, 202, 237). Carotenoid synthases and SqS also
share several highly conserved domains, and it is likely that the
two have a common evolutionary origin (176).
The biosynthesis of carotenoid backbones (and squalene)
has proven to be a complex process (22, 88, 89) (Fig. 5a). The
reaction proceeds in two distinct steps. The first consists of
abstraction of a diphosphate group from a prenyl donor fol-
lowed by 1-1 condensation of the donor and acceptor and loss
of a proton to form a stable cyclopropyl intermediate. In the
second step, the cyclopropyl intermediate is rearranged, the
second diphosphate group is lost, and the resultant carbocation
is quenched after the loss of another proton (Fig. 5a). Bio-
chemical (156) and structural (159) studies have shown that
FIG. 5. Product length determination by CrtM and mutants there-
of. (a) Reaction mechanism of squalene synthase (left pathway) and
CrtM (right pathway). Both enzymes catalyze the head-to-head con-
densation of two molecules of C15PP to yield linear C30 hydrocarbons.
The enzymes employ similar mechanisms involving a common stable
intermediate, presqualene diphosphate (PSPP). The mechanisms dif-
fer only in the final rearrangement step, which is followed in the case
of squalene synthase by reduction of the central double bond. (b)
Crystal structure of human squalene synthase (PDB ID 1EZF). Green
residues are involved in the first half-reaction (formation of PSPP),
while blue residues form the pocket of the second half-reaction in
which PSPP is rearranged. Red residues correspond by sequence align-
ment to F26 and W38 of CrtM, which were found to control the
product size of that enzyme (213, 214). Shown in yellow are the resi-
dues that align with mutations in CrtM that improve both its C30 and
C40 carotenoid synthase activities. (c) Mutation analysis of F26 and
W38 of CrtM. Various site-directed variants of CrtM (indicated by
their one-letter amino acid code) were constructed and tested for their
synthase activity in both C30 and C40 carotenoid pathways. Variants are
arranged from left to right in increasing order with respect to the van
der Waals’ volume of the substituted amino acid. The C30 carotenoid
synthase activity of each variant was estimated from the level of yellow
pigmentation when coexpressed with CrtN. Similarly, the C40 carot-
enoid synthase function of each variant was evaluated in terms of the
level of red pigmentation when coexpressed with CrtE and CrtI. Panels
a and b were made using data from reference 212.
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these two subreactions occur in physically distinct sites in the
enzyme (Fig. 5b).
Carotenoid synthases are quite specific with respect to prod-
uct size, which reflects a strong preference for prenyl diphos-
phate substrates of a particular length. The C40 carotenoid
synthase CrtB does not detectably accept C15PP as a substrate,
while the C30 synthase CrtM accepts two molecules of C20PP to
form C40 carotenoids much less efficiently than it accepts two
molecules of C15PP to form C30 carotenoids (163, 214). Even
though various longer and shorter isoprenyl diphosphates are
made by different organisms (146), no known carotenoids are
derived from them. Terpene synthases also utilize specific pre-
cursors (41), although product specificity can be quite modest
(190).
Carotenoid synthases, positioned early in the biosynthetic
pathway and possessing the ability to discriminate between
isoprenyl diphosphate substrates with different numbers of iso-
prene units, appear to play the role of pathway gatekeeper,
particularly in organisms in which multiple potential substrates
are available. Indeed, as we illustrate, downstream carotenoid
biosynthetic enzymes are less specific than the synthases and
appear to recognize only a particular motif of the substrate. In
the Introduction, we reasoned that gatekeeper enzymes should
be attractive targets for pathway diversification. If carotenoid
synthases could be engineered to accept different prenyl sub-
strates and synthesize carotenoid backbones from them, the
locally specific downstream enzymes might accept these new
backbones and generate the corresponding metabolites. This
would give rise to whole new pathway families. Compared to
the IDSs, however, little is known about the molecular basis for
the substrate and product specificity of carotenoid synthases.
Following the lead of those who studied the IDSs (96, 122,
125, 141, 147, 148, 150–152, 203, 238, 239), we probed the
evolvability of size specificity in the carotenoid synthases by
looking for mutants that complement a non-native pathway.
Using error-prone PCR to perform random mutagenesis, ex-
pressing the mutant genes with the remaining genes necessary
to produce lycopene in E. coli, and screening to find red col-
onies, we identified single amino acid substitutions in the S. au-
reus C30 carotenoid synthase CrtM (F26L or F26S) that confer
the ability to make the C40 backbone just as efficiently as CrtB
(214). Repeating this experiment using a PCR method de-
signed to guarantee that the libraries would be free from mu-
tation at F26 allowed us to uncover two additional amino acid
substitutions, W38C and E180G, that also confer C40 function
on CrtM (213). Mapped onto the crystal structure of human
squalene synthase (SqS [Fig. 5b]), F26 and W38 appear in
helices B and C, respectively, and the side chains of both res-
idues point into the pocket that accommodates the second
half-reaction (rearrangement of the cyclopropyl intermediate).
Replacement of these amino acids with smaller ones signifi-
cantly increased the C40 synthase activity of CrtM (Fig. 5c).
Conversely, the C30 synthase performance was the highest for
wild-type CrtM and decreased with decreasing size of the amino
acid residues at these positions. This analysis led to our pro-
posal that wild-type CrtM is able to perform the rate-limiting
first half-reaction of phytoene synthesis—condensation of two
molecules of C20PP to form the cyclopropyl intermediate, pre-
phytoene diphosphate—but the second half-reaction is pre-
vented from going to completion by steric inhibition of the
normally fast rearrangement step. Unable to convert into phy-
toene in wild-type CrtM, prephytoene diphosphate either re-
mains stuck in the enzyme, departs, or undergoes other types
of rearrangement to yield noncarotenoid products. (A similar
phenomenon is well known for SqS; in the absence of NADPH,
which is required to convert presqualene diphosphate to squa-
lene, SqS produces a complex mixture of nonsqualene com-
pounds including rillingol, 10-hydroxybotryococcene, and 12-
hydroxysqualene [22, 89].) However, in CrtM mutants where
F26 or W38 is replaced with a smaller or more flexible amino
acid, the prephytoene diphosphate formed from two molecules
of C20PP is efficiently rearranged to form phytoene. Thus, the
F26 and W38 mutations apparently modify the product spec-
ificity, not the substrate specificity of CrtM: they do not act by
allowing the enzyme to bind and accept GGPP as a substrate
but, rather, allow the intermediate prephytoene diphosphate to
be converted to phytoene.
Gain of C40 function by mutagenesis of CrtM usually came
at a cost to the original C30 synthase activity. For example,
some enzymes doubly mutated at F26 and W38 showed only
negligible C30 synthase activity. However, other modes of ob-
taining C40 synthase activity were possible. The E180G substi-
tution increased performance in both the C30 and C40 contexts
(212). Mapped onto the SqS structure, E180G is positioned
outside the reaction pocket but close to the site of the first
half-reaction. We think this mutation accelerates the rate-lim-
iting first half-reaction. Several such activating mutations were
found by random mutagenesis of CrtMF26S in a successful
search for improved or restored C30 function (D. Umeno,
unpublished results). All of these activating mutations were
rather far from the reaction center (Fig. 5b, indicated in yel-
low) and enhanced both C30 and C40 synthase activity. These
mutations could be increasing expression level, stability (half-
life in vivo), or specific activity.
Like IDSs, carotenoid synthases appear to be specific, but at
least in the case of CrtM, that specificity is readily altered by
mutation. Furthermore, there are multiple mutational routes
to the same altered phenotype. In contrast, in similar experi-
ments with CrtB, we were unable to find any mutations that
conferred C30 carotenoid synthase function. We are tempted
to speculate that CrtM, by virtue of the fact that it does not
need to select C15PP from C20PP in its natural host (C20PP is
not made in C30 carotenoid-producing organisms), is inher-
ently more evolvable toward accepting C20PP than is CrtB
toward accepting C15PP, because CrtB has always had to select
C20PP over C15PP (the latter is present in all organisms). CrtM
can in fact accept C20PP in a hybrid reaction: when supplied
with both C15PP and C20PP, wild-type CrtM can condense one
molecule of each to synthesize a C35 carotenoid backbone (see
below). CrtM has thus proven to be an evolvable enzyme while
CrtB has not, at least with respect to the specific tasks of
accepting a larger (CrtM) or smaller (CrtB) substrate. As was
the case with the IDSs, a single amino acid substitution was
sufficient to increase the size of the products synthesized by
CrtM. Furthermore, as we describe below, the mutants of
CrtM that function in a C40 carotenoid biosynthetic pathway
are also capable of synthesizing even larger carotenoid back-
bones when supplied with the appropriate precursors.
Carotenoid desaturases. Phytoene and 4,4-diapophytoene,
the (colorless) products of the natural carotenoid synthases,
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have three conjugated double bonds in the center of their
backbones. Formation of carotenoid pigments requires exten-
sion of this conjugated double-bond system. The photochem-
ical properties of a carotenoid (including its color) depend
strongly on the size of the chromophore and therefore on the
number of desaturation steps catalyzed by the desaturase en-
zyme(s). A C40 backbone can accommodate up to 15 con-
jugated double bonds, corresponding to six sequential de-
saturation steps. C30 carotenoids can undergo at most four
desaturation steps (11 conjugated double bonds).
In general, bacterial C40 desaturases are functional on C30
carotenoids and vice versa. It is proposed that carotenoid de-
saturases recognize only a portion of the substrate molecule
common to both C30 and C40 carotenoid backbones (163, 174).
Subsequent carotenoid-modifying enzymes are also often lo-
cally specific (see below). Because each of the desaturation
intermediates represents a branch point for further diversifi-
cation by downstream enzymes, altering and controlling the
desaturation step number is key for creating extensive molec-
ular diversity (70). Nature has done this: many different carot-
enoid desaturases are known in C40 pathways, each with its
specific step number. Carotenoid desaturases which primarily
catalyze two, three, four, and five desaturation steps are known;
one-step and six-step desaturated carotenoids have been re-
ported only as minor products in natural carotenogenic organ-
isms. The ability of carotenoid desaturases to accept different
substrates was demonstrated when C30 and C40 desaturases
were tested in each other’s pathway (163, 214). C40 desaturases
from Erwinia (four-step enzymes), Rhodobacter (three-step),
and Anabaena (two-step) are all active on C30 substrates. Sim-
ilarly, the C30 desaturase CrtN showed measurable activity in a
C40 pathway. The localized specificity of these desaturases has
been exploited in engineered pathways (211) (see below).
The desaturase step number can be inferred from the color
(or color change) of the carotenoids produced in vivo. This
provides an excellent basis for screening mutant desaturases in
the laboratory for the ability to accept new substrates or for
changes in product specificity. Using this principle, Schmidt-
Dannert et al., working in this laboratory, readily isolated de-
saturase variants with altered step number in a C40 pathway
(181). Starting from a library made by DNA shuffling of two
closely related four-step phytoene desaturases (crtI from P. ag-
glomerans [E. herbicola] and crtI from Pantoea ananatis [E. ure-
dovora]), they isolated one four- to six-step variant, CrtI14 (Fig.
6), as well as 20 variants that catalyze fewer (less than four)
steps. Wang and Liao conducted similar experiments with the
three-step desaturase from Rhodobacter sphaeroides (222). Two
rounds of random mutagenesis by error-prone PCR and color
screening resulted in variants that accumulated the four-step
product, lycopene. At least five different mutations increased
the step number of this desaturase. Furthermore, some com-
binations of mutations resulted in yet higher production of
lycopene (222).
We recently investigated the ability of the C30 desaturase
CrtN from S. aureus to alter its product specificity on mutation.
CrtN is a three-step desaturase in S. aureus (226). E. coli col-
onies expressing this enzyme together with the C30 synthase
CrtM develop a yellow-orange color due to the production of
4,4-diaponeurosporene (three steps) and 4,4-diapolycopene
(four steps). When E. coli were transformed with a library of
crtN mutants made by error-prone PCR, the variation in the
colors of the colonies (Fig. 7), from pale to weakly fluorescent,
lemon, yellow, orange, and red, was striking. To our surprise,
approximately 30% of the colonies were lemon or yellow, dif-
ferent from the wild type. These were shown to produce 4,4-
diapophytofluene (one-step desaturation) and 4,4-diapo--
carotene (two steps) (Umeno, unpublished). We also isolated
a large number of red mutants, which were found by high-
performance liquid chromatography analysis to produce main-
ly 4,4-diapolycopene (four steps) (Fig. 7).
Multiple experiments have thus shown that bacterial carot-
enoid desaturases are evolvable. The high frequency of color
variants in the mutant libraries suggests that there are multiple
mechanisms by which the step number can change upon mu-
tation. It is possible that most (if not all) mutants with altered
desaturation step number have acquired this change in product
specificity by up- or down-regulating total desaturase activity
rather than by altering intrinsic enzyme specificity, which we
would expect to occur only rarely. The higher frequency of
mutants with lower desaturation number compared to mutants
with elevated desaturation number supports this idea, because
there are many more paths downward with respect to a prop-
erty such as activity or expression level. Many mutant desatu-
rases with elevated step numbers turned out to have mutations
near a putative flavin adenine dinucleotide (FAD)-binding do-
main (181, 222), indicating that FAD access might be a source
of step number control.
Carotenoid desaturases tend to exhibit more well-defined
product specificity in their natural hosts than when (over)ex-
pressed in a heterologous host. For instance, CrtN appears to
be a three-step enzyme and produces almost exclusively 4,4-
diaponeurosporene in S. aureus (226). In a heterologous host,
however, its desaturation step number is less distinct. Several
groups have reported that CrtN produces the four-step 4,4-
diapolycopene as a major product in an E. coli system (118,
163, 211, 214). Desaturase step number can also be altered by
manipulation of enzymes further downstream in the carot-
enoid pathway (69). It is not surprising that altering the envi-
ronment of a desaturase can alter its product specificity. If
downstream enzymes that normally remove certain desatura-
tion products are not present, the desaturase may have an op-
portunity to catalyze further desaturation steps. In addition, if
these enzymes associate in complexes, expression of a desatu-
rase with other carotenoid biosynthetic genes from different
organisms could yield complexes with altered or suboptimal
substrate transfer properties, which could affect the desatura-
tion step number. Further research should shed light on the
source of desaturase specificity and on the ways in which spec-
ificity can be altered.
Carotenoid cyclases. Cyclization is another important branch
point for carotenoid diversification. Cyclic carotenoids are pro-
duced in plants, algae, and photosynthetic bacteria, and en-
zymes catalyzing the formation of different cyclic products
have been characterized (11, 52, 54, 84, 109–111, 194). A given
cyclase usually produces only one kind of ring structure (32).
However, an exception was recently reported by Stickforth et
al., who showed that the enzyme CrtL-e from the cyanobacte-
rium Prochlorococcus marinus is both a - and an ε-cyclase
(194). The cyclases share nearly identical mechanisms, differ-
ing only in the final rearrangement step (Fig. 8a).
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Although lycopene, with its two -ends, is the natural sub-
strate for most known cyclases, studies have shown that some
cyclases can act on a wider range of substrates (Fig. 8b). An
ability to convert different substrates was reported for Arabi-
dopsis ε-end lycopene cyclase, which can cyclize the -end of
neurosporene to form 	-zeacarotene (53, 54). Britton noted
that the only apparent requirement for recognition and catal-
ysis by carotenoid cyclases is that the substrate have a -end
(Fig. 8b) (32). However, Takaichi et al. showed that bacterial
and plant lycopene cyclases can cyclize the 7,8-dihydro--end
of -carotene and neurosporene (199). Recently, we showed
that E. uredovora -cyclase and a plant ε-cyclase can efficiently
cyclize nonnatural carotenoids with a C35 backbone (211). Sim-
ilarly, Lee et al. reported that the C30 carotenoid 4,4-diapo-
neurosporene can be cyclized by Erwinia -cyclases, leading to
the novel cyclic C30 carotenoid diapotorulene (118). Another
interesting enzyme is capsanthin-capsorubin synthase (CCS)
from Capsicum annuum. The primary natural function of CCS
is to rearrange the epoxidized cyclic carotenoids antheraxan-
thin and violaxanthin into the cyclopentyl 
-end products cap-
santhin and capsorubin. When expressed in E. coli, however,
CCS was shown to also possess lycopene -cyclase activity,
cyclizing both ends of lycopene to yield ,-carotene (84).
All known -cyclases, except one recently discovered in a
marine bacterium (207), create rings at both ends of lycopene.
In contrast, known ε-cyclases except those from Lactuca sativa
(lettuce) and the flower Adonis aestivalis generate monocyclic
carotenoids (52). In an attempt to manipulate the ring number
and understand how it is determined, Cunningham and Gantt
constructed a series of single-crossover chimeras of one-step
(Arabidopsis thaliana) and two-step (Lactuca sativa) ε-cyclases
(52). Analysis revealed a region of six amino acids involved in
ring number determination. Further mutagenesis experiments
identified single-amino-acid substitutions that alter ring num-
ber specificity: in the lettuce two-step cyclase Dy4, substitution
of H457 with leucine converted the enzyme into a monocy-
FIG. 6. Extension of laboratory-evolved pathways to 3,4,3,4-tetradehydrolycopene and torulene by coexpression of downstream carotenoid
modifying enzymes. Boxed structures had not been previously identified in biological material. Native enzyme reactions are shown with black
arrows. Gray arrows depict reactions not seen in natural organisms, and laboratory-evolved enzymes are written in gray lettering. Double arrows
indicate enzymatic modification of both ends of a carotenoid substrate. Enzyme abbreviations: CrtA, spheroidene monooxygenase; CrtI, phytoene
desaturase from E. uredovora (current approved name, Pantoea ananatis) (four-step), CrtI14, laboratory-evolved mutant of CrtI (four- to six-step)
(180); CrtO, ,-carotene 4,(4)-ketolase; CrtU, ,-carotene desaturase; CrtX, zeaxanthin glycosylase; CrtY, lycopene -cyclase; CrtY2, labo-
ratory-evolved mutant of CrtY (180); CrtZ, ,-carotene 3,(3)-hydroxylase. Biosynthesis of oxygenated derivatives of -carotene and neuros-
porene was attributed to early termination by CrtA of the desaturation sequence of CrtI, which is normally a four-step desaturase (118). Although
CrtA is primarily a ketolase, it is thought to catalyze the introduction of both hydroxy groups of phillipsiaxanthin (C. Schmidt-Dannert, personal
communication). This figure was made using data from reference 118.
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clase; the corresponding L448H mutation in Y2, the Arabidop-
sis monocyclase, resulted in an enzyme that forms two rings.
Thus, ring number specificity can be modulated with a single
amino acid substitution. The authors of this study suggested
that the residues they identified may play a role in dimer
formation (52). Lycopene may be oriented in the plasma mem-
brane such that one of its ends is more accessible to the cyclase
than the other. Only when cyclase dimers are formed does
binding of the more accessible end bring the less accessible end
close enough to the other subunit for it to be cyclized as well.
An alternative but similar explanation for the above observa-
tions is that the mutations alter the cyclase oligomerization
state within a carotenoid-synthesizing complex. For example,
FIG. 7. The step number of the C30 desaturase CrtN is readily
modified by mutation. A library of mutant crtN alleles was coexpressed
with the C30 carotenoid synthase crtM in E. coli. Wild-type CrtN is a
three- to four-step desaturase when expressed in E. coli, causing col-
onies to appear orange (inset). Colonies harboring CrtN mutants with
increased step number were deep orange and red (highlighted by
arrows), reflecting the longer carotenoid chromophores formed by
these mutant desaturases. Colonies harboring mutants with decreased
step number appear yellow/lemon, while colonies with nonfunctional
or single-step desaturases are pale since these products are colorless.
Shown below are the possible C30 desaturation products and the de-
saturases that synthesize them. CrtN1–3 are discovered mutants of
CrtN with altered desaturation step number. Each colored box depicts
the approximate color of the carotenoid in white light. Molecules
without colored boxes are colorless. Abbreviations: lacP, lac promoter;
wt, wild type.
FIG. 8. Cyclization of carotenoids. (a) Mechanism of carotenoid
cyclization. Lycopene with its two -end groups is the preferred sub-
strate for all known carotenoid cyclases. All cyclases produce the same
carbocationic intermediate on protonation of C-2 of the substrate.
Product ring type (, ε, or ) is determined by which proton (a, b, or
c in the figure) is eliminated in the subsequent rearrangement step.
This panel was made using data from reference 32. (b) Substrates
accepted by lycopene cyclases. The shaded portion(s) of each structure
is cyclized. The first three compounds, with their -end groups, have
long been known as natural substrates for lycopene cyclases. The
remaining seven structures, including neurosporene with its 7,8-dihy-
dro--end (left side of molecule) and -carotene with two 7,8-dihydro-
-ends, have more recently been shown to be cyclized.
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when one cyclase subunit is present in each complex, carot-
enoid products are cyclized on only one end whereas com-
plexes with two cyclase subunits would cyclize carotenoids at
both ends. Association of cyclase monomers in a complex
would depend on their interactions with each other and the
other constituents of the complex, and a single amino acid
substitution could be sufficient to disrupt (or promote) this
association. It is also possible that the single amino acid sub-
stitutions described above alter the enzyme’s intrinsic prefer-
ence for the carotenoid substrate that has already been cy-
clized on one end. The H457L mutation may reduce the
preference of Dy4 for the monocyclic substrate, while the
L448H mutation increases the ability of Y2 to cyclize it.
CrtI14 is a four- to six-step desaturase, and E. coli cells ex-
pressing this variant along with CrtE (a C20PP synthase) and
CrtB (a C40 carotenoid synthase) can synthesize 3,4,3,4-tetra-
dehydrolycopene (Fig. 6) (181). When CrtY, the -cyclase
from Erwinia, was coexpressed with these enzymes, the cells
synthesized exclusively ,-carotene—the same product made
by cells expressing wild-type CrtE, CrtB, CrtI, and CrtY. Di-
rected evolution, however, could create a pathway leading to a
new cyclized product: after performing DNA shuffling to make
a library of CrtY variants and coexpressing these with CrtI14
and CrtE, Schmidt-Dannert et al. identified clones that accu-
mulated the monocyclic carotenoid torulene (Fig. 6) (181).
Pigment analysis from cells harboring the CrtY mutants includ-
ing CrtY2 (Fig. 6) revealed torulene together with lycopene,
3,4,3,4-tetradehydrolycopene, ,-carotene, and ,-caro-
tene. Torulene-producing variants were also discovered when
the CrtY library was created by error-prone PCR (Umeno,
unpublished). These mutants made up 2 to 5% of the library.
This high frequency of torulene-producing mutants suggests
that the torulene pathway emerged by down-regulation of cy-
clase activity. Mutants of CrtY with decreased catalytic activity
would compete less efficiently with CrtI14 for the ends of the
carotenoid substrate, with the result that only one end is cy-
clized while the other is desaturated, leading to torulene. Al-
ternatively, the CrtY mutants found in the torulene-producing
clones may be compromised in their ability to form dimers,
either as part of larger carotenoid enzyme complexes or not.
Although the underlying mechanisms for the changes in
cyclase step number remain obscure, it is clear that carotenoid
cyclases are evolvable: their phenotype can change dramati-
cally with a small number of mutations, and there appear to be
multiple pathways to a particular phenotype. As we show in the
next section, combining evolved carotenoid desaturases and
cyclases with locally specific enzymes further downstream al-
lows an even larger natural product space to be sampled. To
date, carotenoid cyclases have not been evolved in the labora-
tory for altered product specificity, for example to convert a
-cyclase to an ε-cyclase or vice versa. These cyclases have very
similar chemical mechanisms (Fig. 8a), and we predict that
cyclase product specificity will be easily modified by mutation.
Enzymes catalyzing further modifications. Numerous en-
zymes catalyzing hydroxylation, epoxidation, glycosylation, O
methylation, acyl transfer, prenyl transfer, oxidative cleavage,
and other reactions on cyclic and acyclic carotenoids have been
cloned and expressed in E. coli (for reviews, see references 175
and 180). Misawa et al. made an early demonstration of the
localized specificity of these modifying enzymes (135). Intro-
duction of the -end 3-hydroxylase CrtZ and the -end 4-ke-
tolase CrtW into E. coli harboring a ,-carotene pathway led
to the accumulation of as many as nine carotenoids (Fig. 3).
Recent work has revealed that many carotenoid-modifying en-
zymes act on a range of substrates (5, 16, 118, 191, 197).
Lee et al. exploited the catalytic promiscuity of a number of
carotenoid-modifying enzymes in an E. coli system to extend
laboratory-evolved pathways to 3,4,3,4-tetradehydrolycopene
and torulene, generating biosynthetic routes to several carote-
noids not identified in nature (118) (Fig. 6). CrtA, an oxygen-
ase from Rhodobacter capsulatus that normally acts on the
methoxy carotenoid spheroidene, was found to insert one keto
group into -carotene, neurosporene, and lycopene and to in-
sert two keto groups into tetradehydrolycopene. Monocyclic
torulene, synthesized via the pathway constructed using the
laboratory-evolved desaturase and cyclase (181), served as a
substrate for CrtO, a ,-carotene ketolase from Synechocystis
sp. strain PCC 6803; CrtU, a ,-carotene ring desaturase from
Brevibacterium linens; and CrtZ, a ,-carotene hydroxylase
from E. herbicola. In addition, 3-hydroxytorulene, the product
of the action of CrtZ on torulene, was further metabolized by
CrtX, a zeaxanthin glycosylase from E. herbicola, leading to the
synthesis of torulene-3--D-glucoside (Fig. 6). In this work, the
pathway to torulene generated by directed evolution of two
upstream carotenoid biosynthetic enzymes was extended in
several different directions by adding genes for further trans-
formations. Owing to their intrinsic localized specificity, coex-
pression of these downstream modifying enzymes with the
foreign torulene pathway resulted in a series of novel torulene
derivatives.
There are no reports yet of directed evolution of carotenoid
oxygenases or post-cyclase carotenoid-modifying enzymes. Work
by Sun et al. (197), however, provides an interesting example of
how modifying the sequence of a carotenoid hydroxylase can
alter the enzyme’s product distribution. The ,-carotene hy-
droxylase from A. thaliana catalyzes two hydroxylation steps,
converting ,-carotene to zeaxanthin (90%) in A. thaliana
and when expressed in E. coli (Fig. 9). Noticing that this en-
zyme had an N-terminal extension of more than 130 amino
acids compared with other known ,-carotene hydroxylases,
Sun et al. expressed in E. coli a truncated version of the Ara-
bidopsis hydroxylase lacking the N-terminal 129 amino acids.
The truncated enzyme primarily catalyzed only one hydroxy-
lation step, and -cryptoxanthin (Fig. 9) accumulated as the
main product (75%) (197). The molecular basis for this al-
tered hydroxylation step number is not known; the authors
speculated that truncation yielded an enzyme deficient in the
ability to form dimers.
Carotenoid cleavage enzymes comprise an important class
of carotenoid-modifying enzymes. Enzymatic oxidative cleav-
age of carotenoids in both carotenogenic and non caroteno-
genic organisms creates diverse “apocarotenoid” structures,
many of which are highly biologically significant (71). Well
known products of carotenoid cleavage enzymes include reti-
nol and retinoic acids (mammalian hormones) (220), abscisic
acid (a plant growth regulator) (186, 236), and the plant pig-
ment bixin (28). The localized specificity of several carotenoid
cleavage enzymes has recently been demonstrated. One impor-
tant cleavage enzyme is ,-carotene-15,15-monooxygenase
(CM) (formerly named ,-carotene-15,15-dioxygenase be-
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fore the enzyme was shown to employ a monooxygenase mech-
anism [121]), which converts ,-carotene into retinal (Fig.
10a) (158, 165, 219, 231, 232). CM cleaves substrates other
than ,-carotene, such as 	-carotene (228) and -cryptoxan-
thin (Fig. 10a) (123, 228). The enzyme has a strong preference
for substrates with at least one unsubstituted -end (123, 228)
and appears to always cleave a substrate’s central 15-15 dou-
ble bond (115). Recently discovered homologs of CM cata-
lyze the asymmetric cleavage of carotenoids (28, 98, 186). One
murine oxygenase cleaves ,-carotene at the 9-10 double
bond (Fig. 10b), yielding -apo-10-carotenal (C27) and -ion-
one (C13) (98). This enzyme also catalyzes the cleavage of
lycopene, resulting in the formation of apolycopenals (Fig.
10b) (98). Another carotenoid cleavage enzyme from A. thali-
ana was shown to cleave an impressive array of different sub-
strates in vitro (Fig. 10c) (185). Thus, carotenoid cleavage
enzymes are quite versatile and their localized specificity may
be exploited to generate diverse new carotenoid derivatives in
the laboratory.
Creation of Pathways to Carotenoids with
New Carbon Scaffolds
Given the proven evolvability of different enzymes involved
in carotenoid biosynthesis, we investigated the possibility of
creating routes to whole new families of carotenoids built on
scaffolds other than the symmetric C30 and C40 backbones seen
in nature. We reasoned that if carotenoid synthases could be
engineered to accept different substrates and synthesize unnat-
ural carotenoid backbones, locally specific downstream en-
zymes might accept and modify these backbones, leading to
whole new families of carotenoids. The downstream enzymes
could also be evolved to produce still more novel products or
to function more efficiently on their new substrates. Compared
to increasing the diversity of known C30 or C40 carotenoids by
altering the specificity of downstream pathway enzymes, gen-
erating entire new pathway families by focusing on upstream
enzymes has a much greater capability to explore new carot-
enoid structures. The entire space of carotenoids built on non-
C30 or non-C40 backbones, for example, is uncharted. Gener-
ating novel chain length carotenoids can also be viewed as a
rigorous test of carotenoid pathway evolvability.
A particularly exciting goal is to generate carotenoids with
chromophores or physico-chemical properties not possible in
carotenoids based on natural backbones. Millions of years of
evolution gave rise to the 700 carotenoids known in nature.
Laboratory evolution of new carotenoid pathways based on
unnatural backbones has the potential to at least double or
triple this diversity. If significant numbers of new products can
be generated, laboratory pathway evolution would be validated
as an important tool for preparing large natural product librar-
ies from which compounds with valuable properties and bio-
logical activities can be discovered.
A C35 carotenoid pathway. We recently discovered that the
C30 synthase CrtM could assemble a 35-carbon backbone when
supplied with C15PP and C20PP precursors (211). When trans-
formed with crtE from E. uredovora (encoding a C20PP synthase)
and crtM from S. aureus, E. coli cells accumulate 4-apophy-
toene, an asymmetrical C35 carotenoid formed via heterocon-
densation of C15PP and C20PP (Fig. 11). This novel backbone
comprised 40 to 60% of total carotenoids, with C30 4,4-diapo-
phytoene and C40 phytoene as minor components.
We found that the C35 backbone was further metabolized by
various C40- and C30-carotenoid biosynthetic enzymes, creating
a family of new C35 carotenoids (Fig. 11). Carotenoid desatu-
rases from C40 (Erwinia CrtI) or C30 (Staphylococcus CrtN)
pathways efficiently converted the C35 backbone to yield acyclic
carotenoids with different levels of desaturation (211). It is
interesting that the C30 desaturase CrtN showed higher step
number (four or five steps) in the C35 pathway than in its native
C30 pathway (three or four steps) or in a C40 pathway (two or
three steps). Thus, E. coli cells expressing CrtN develop an in-
tense red color only when they produce the C35 substrate. The
larger number of desaturation steps catalyzed on a C35 sub-
strate may reflect a tradeoff between the enzyme’s substrate
preference and the number of desaturation steps the substrate
can possibly undergo. CrtN most probably prefers its native
C30 substrate, but the C40 substrate can undergo more desatu-
rations. With a C35 substrate, a balance of these two factors can
yield the high observed step number if, for example, the en-
zyme (or enzyme complex) binds the “C30-like” end of the C35
substrate strongly and catalyzes one or more additional desatu-
ration steps on the “C40-like” end compared with a C30 sub-
FIG. 9. Alteration of product specificity of the ,-carotene hy-
droxylase from Arabidopsis thaliana. The wild-type enzyme catalyzes
two hydroxylation steps, converting ,-carotene to zeaxanthin when
expressed in either A. thaliana or E. coli. When the N-terminal 129
amino acids (aa) were removed, the truncated enzyme expressed in
E. coli catalyzed only one hydroxylation step, leading primarily to
synthesis of -cryptoxanthin (197).
FIG. 10. Several carotenoid cleavage enzymes display localized specificity. Gray arrowheads show bonds cleaved. (a) ,-Carotene-15,15-
monooxygenase (CM) can cleave substrates with an unsubstituted -end (123, 228). (b) Murine ,-carotene-9,10-oxygenase (CO9-10) can
also cleave lycopene, leading to uncharacterized apolycopenals (98). (c) One carotenoid cleavage dioxygenase from A. thaliana (AtCCD1) cleaves
at least six different carotenoid substrates, leading to a variety of products (185). The downward arrow from C14 dialdehyde indicates that this
product was detected from all six substrates shown.
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strate. Other scenarios can also plausibly lead to the same
result.
Assembling the enzymes for the new backbone (CrtE and
CrtM) with wild-type desaturases provided some of the possi-
ble C35 desaturation products. The remaining desaturation
products were obtained by directed evolution. Random mu-
tagenesis of carotenoid desaturases expressed in E. coli syn-
thesizing the C35 carotenoid backbone generated colonies hav-
ing a spectrum of colors, which reflected desaturase mutants
with altered step numbers (211). In fact, individual clones that
produced each of the possible acyclic C35 carotenoids as the
main product were identified (Fig. 11). Addition of the -cy-
clase CrtY from E. uredovora or the ε-cyclase Dy4 (L. sativa)
further diversified the C35 pathway, yielding at least four new
monocyclic C35 carotenoids (Fig. 11).
As discussed in the Introduction, some fungi naturally accu-
mulate carotenoids with 35 carbon atoms (12, 14, 164, 215). All
of these are monocyclic oxygenated carotenoids (xanthophylls)
and are believed to result from the action of an unidentified
oxidative cleavage enzyme on C40 carotenoids such as torulene.
Disruption of cyclase activity in Neurospora crassa resulted in
the biosynthesis of an acyclic C35 xanthophyll (12). These C35
xanthophylls and the biosynthetic routes leading to their for-
mation are qualitatively different from laboratory-generated C35
carotenoids biosynthesized via heterocondensation of C15PP
and C20PP. Notably, the direct route to the C35 carotenoid back-
bone 4-apophytoene opens many possibilities for further path-
way diversification by downstream enzymes (desaturases, cy-
clases, etc.) whereas many fewer options exist for diversifying
the already desaturated, cyclized, and oxygenated C35 carote-
noids found in fungi.
Because C35 carotenoids have asymmetric backbones, each
desaturation step can potentially yield more than one product,
depending on the direction of the desaturation step (and the
previous steps). Thus, acyclic C35 carotenoids with 3, 5, 7, 9, 11,
and 13 conjugated double bonds can assume 1, 2, 3, 3, 2, and
1 (a total of 12) possible structures, respectively. In this sense,
the C35 pathway is inherently more complex and explores a
much larger “structure space” than do pathways based on the
symmetric C30 and C40 carotenoid backbones. Cyclization and
other modifications of the backbone can further increase the
number of possible C35 carotenoids. Considering their broad
substrate tolerances, we expect that other carotenoid-modify-
ing enzymes will also be functional in this C35 pathway and that
one could make many hundreds of new carotenoids. The gen-
eration of a new, full-fledged C35 carotenoid biosynthetic path-
way in the laboratory is a convincing demonstration of the
evolvable nature of carotenoid biosynthetic enzymes and path-
ways and serves as an excellent illustration of how gene assem-
bly coupled with directed evolution can rapidly access diverse
chemical structures.
FIG. 11. Generation of a C35 carotenoid pathway by gene assembly and directed enzyme evolution (211). When supplied with C15PP and C20PP,
the C30 carotenoid synthase CrtM produces the C35 carotenoid backbone, 4-apophytoene. By coexpressing C30 or C40 desaturases and mutants
thereof (gray), different clones could be found that produce each possible acyclic C35 carotenoid as the main product. E. uredovora (P. ananatis)
-cyclase (CrtY) and L. sativa ε-cyclase (Dy4) were shown to cyclize two of the C35 substrates, leading to four different cyclic C35 carotenoids. All
10 C35 carotenoids in this figure had never been previously reported.
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Carotenoids with longer backbones. The C25PP isoprenoid
precursor farnesylgeranyl diphosphate and the C30PP hexapre-
nyl diphosphate serve as components of archaebacterial mem-
brane lipids and quinone side chains, respectively. They have
never been found to be incorporated into carotenoids. How-
ever, these longer analogs of the C40 carotenoid precursor
C20PP could in principle be used in the biosynthesis of carot-
enoid backbones having 45, 50, 55, or 60 carbon atoms. Simi-
larly, the monoterpene precursor geranyl diphosphate (C10PP)
could, in theory, be used to construct C20, C25, or asymmetric
C30 carotenoids. All these backbone structures would be pos-
sible, provided that there were synthases capable of condens-
ing these substrates. Although carotenoid synthases with these
activities are not known in nature, we reasoned that an existing
synthase could be engineered to make at least some of these
new backbones.
As discussed above, we had probed carotenoid synthase
evolvability by screening for mutants of CrtM that function as
a C40 synthase and mutants of CrtB that function as a C30 syn-
thase. CrtM and CrtB diverged long ago and have only 30%
amino acid sequence identity. Nonetheless, CrtM was readily
converted to a C40 synthase (214). Sequencing confirmed that
multiple single-substitution pathways leading to this phenotype
were possible (213). We then tested whether one or more of these
CrtM mutants might be able to synthesize even larger back-
bones.
To supply a C25PP substrate in E. coli, we constructed and
expressed the Y81A variant of the C15PP synthase from B. stea-
rothermophilus (BstFPSY81A). This variant was shown by Ohnu-
ma’s group to produce C25PP as the main product in vitro (150,
151). When coexpressed with BstFPSY81A, the single mutants
CrtMF26L and CrtMF26S discovered in our original C40 pathway
screening experiment (214) synthesized 16-isopentenylphy-
toene (the C45 carotenoid backbone, C20  C25) and 16,16-
diisopentenylphytoene (the C50 backbone, C25  C25) (Fig.
12a). Site saturation mutagenesis at residues 26, 38, and 180
(also discovered to play a role in conferring C40 function on
CrtM [213]) resulted in several double and triple mutants with
improved ability to synthesize C45 and C50 carotenoid back-
bones (212). These carotenoid backbones have never been re-
ported in nature.
Interestingly, some of the new CrtM-based C45 and C50
synthases showed almost no activity in the original C30 pathway
(212). Thus, carotenoid synthases, although highly substrate-
specific in their natural pathways, can both broaden and shift
specificity with minimal genetic change. We are interested in
finding whether these variants can be engineered further to
become producers of C50 carotenoids exclusively (i.e., no
smaller side products) or to generate even larger carotenoids,
with 60- or even 70-carbon chains. Although such long struc-
tures may not be biologically relevant (and may even be toxic),
we might be able to make them in an engineered pathway in
E. coli.
When transformed with crtI (phytoene desaturase), E. coli
harboring the C45-C50 pathway accumulated a deep red color
not seen when CrtI is expressed in cells producing only C40
carotenoids (Fig. 12b). Further analysis revealed that the C45
backbone is completely metabolized by CrtI, although residual,
undesaturated C50 carotenoid backbones have been detected
in some cell extracts (A. Tobias, unpublished data). Given the
proven evolvability of carotene desaturases and cyclases and
the localized specificity of the carotenoid-modifying enzymes
further downstream, we envision that it will be possible to
generate many new carotenoids based on these backbones.
Whereas the fully desaturated, red C40 carotenoid 3,4,3,4-
tetradehydrolycopene has a chromophore consisting of 15 con-
jugated double bonds, C45 and C50 carotenoid backbones can
accommodate 17 and 19, respectively. Extension of a conju-
gated system increases the wavelength(s) of light absorbed by
a molecule and predictably changes the molecule’s color as
observed under white light (33). Dodecapreno--carotene, a
chemically synthesized analog of ,-carotene with 19 conju-
gated double bonds, was reported to absorb light at wave-
lengths longer than 600 nm and to possess bordeaux red to
blue-violet pigmentation, depending on the solvent (93). Two
of this molecule’s conjugated double bonds are contributed by
the two sterically-hindered -ionone groups. Therefore, just as
lycopene with 11 all-trans-conjugated double bonds absorbs
longer-wavelength light than ,-carotene with 9 trans plus 2
beta double bonds, a linear, all-trans carotenoid with 19 con-
jugated double bonds would absorb even longer-wavelength
light and would possess even further blue-shifted pigmentation
than dodecapreno--carotene. Carotenoids with 19 all-trans
double bonds would have possible uses as colorants and might
possess interesting or unique antioxidant properties.
DISCUSSION AND FUTURE DIRECTIONS
Revised View of Carotenoid Biosynthetic Pathways
Carotenoid biosynthetic pathways have been described as
having a tree-like organization, as depicted in Fig. 1 (8). The
conserved upstream reactions leading to backbone synthesis
form the trunk, which supports many branches (and sub-
branches) representing increasingly diverse and species-spe-
cific downstream steps. However, many examples outlined in
this review have shown that enzymes from one branch can
often convert substrates from a different branch. Thus, in light
of the ease with which it is now possible to combine carotenoid
biosynthetic genes from diverse sources in recombinant organ-
isms, pathway engineers might be better served by replacing
the carotenoid “tree” with a more web-like model that empha-
sizes the interconnectivity of enzymes and metabolites and
deemphasizes the natural circumstances in which they are
found. In addition, the tree model, with its conserved trunk
and variable branches, implies that the major mode of diversity
generation is through the addition of new branches and sub-
branches. However, we now know that an important source of
new carotenoid diversity is the generation of new trunks (new
backbones), which can quickly be filled with many branches of
their own by using enzymes taken from nature’s extant pathway
branches and evolving them in their new pathway context.
Future Challenge: Specific Pathways
To date, most laboratory-evolved and many engineered
pathways accumulate novel carotenoids as components of a
complex mixture. This may be fine and sufficient for the dis-
covery of new compounds, but to be practically useful as a
synthetic route to a specific compound, for example, the path-
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way must undergo further engineering to become more spe-
cific. Natural carotenoid pathways, which tend to produce only
a small number of end products, probably followed a similar
course of “pruning” many products down to a chosen few. As
laboratory evolution experiments demonstrate, invention is an
overnight event but shaping newly discovered pathways into
mature, specific ones can require much subsequent engineer-
ing effort. In the laboratory thus far, we have succeeded only in
the first step, and real work remains. We list several possible
approaches to converting a newborn, nonspecific pathway into
one that makes a single novel metabolite.
Evolving enzyme specificity. The most straightforward (but
maybe the most labor-intensive) way to control pathway spec-
ificity is to engineer more specific biosynthetic enzymes. Most
laboratory-evolved enzymes, however, show broadened rather
than shifted specificity, and therefore the pathways containing
them accumulate a combination of old and new products. In
contrast, nature often does a perfect job, such that two related
enzymes (with a common ancestor but now sitting in different
pathways) show no overlap in their substrate or product ranges.
We think that pathways specific for newly discovered me-
tabolites can be engineered, possibly after accumulating neu-
tral mutations (in the context of the desired pathway) and
certainly by directly screening for mutants that produce less of
the old compounds while maintaining (or even improving)
their ability to synthesize the new ones. The laboratory-discov-
ered C35, C45, and C50 carotenoid pathways provide sophisti-
cated experimental systems for testing this approach to dealing
with what is a central, and challenging, problem in metabolic-
pathway engineering. In addition, such experiments may con-
tribute to our understanding of the early evolution of metab-
olism. The increasingly favored “patchwork” model of pathway
FIG. 12. Biosynthesis of carotenoids with C45 and C50 backbones (212). (a) Expression of the Y81A variant of the C15PP synthase from B.
stearothermophilus (BstFPSY81A) led to the production of C20PP and C25PP in E. coli. Additional coexpression of variants of the C30 carotenoid
synthase CrtM mutated at F26 and/or W38 (CrtMmut) resulted in biosynthesis of the C45 carotenoid backbone 16-isopentenylphytoene (C20  C25)
and the C50 backbone 16,16-diisopentenylphytoene (C25  C25). Both of these larger carotenoids had never been previously reported. (b) E. coli
cells expressing BstFPSY81A, CrtMF26A,W38A, and the C40 desaturase CrtI accumulated as yet uncharacterized desaturated carotenoids with a deep
red color (third row). Shown for color comparison is the acetone extract of an E. coli culture expressing CrtM and CrtN and synthesizing the C30
carotenoids 4,4-diaponeurosporene and 4,4-diapolycopene (first row) and the acetone extract of an E. coli culture expressing CrtE, CrtB, and CrtI
and synthesizing the C40 carotenoids lycopene and 3,4,3,4-tetradehydrolycopene (second row). Abbreviations: lacP, lac promoter; Eu, Erwinia
uredovora (current approved name, Pantoea ananatis).
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evolution states that the specific metabolic pathways we ob-
serve today evolved from leaky assemblages of nonspecific
enzymes (90, 171, 233) but provides no molecular explanation
for how this happened. Experiments aimed at evolving path-
way specificity in the laboratory would permit researchers to
track the impact of each genetic change as the pathways ac-
quire greater specificity, and they should therefore provide
molecular insight into this poorly understood process.
Designed channeling. Channeling of intermediates between
successive enzymes in a pathway can eliminate undesirable
fluxes and byproducts. As mentioned above, there is evidence
supporting the existence of carotenoid biosynthetic enzyme
complexes, although we do not know what role such complexes
might play in pathways assembled in a recombinant organism.
Designing enzyme complexes that can channel or shuttle in-
termediates from one enzyme or catalytic site to the next in a
particular sequence may find a use in directing the pathway
toward efficient production of desired metabolites. Nature dis-
covered this strategy for other metabolites, giving rise to the
marvelous enzymatic assembly lines that synthesize polyketides
and nonribosomal peptides (reviewed in reference 169).
In an effort to engineer substrate channeling between suc-
cessive enzymes in a biosynthetic pathway, Brodelius et al.
fused a C15PP synthase with a sesquiterpene cyclase (34). The
resultant fusion enzyme was more efficient at converting iso-
pentenyl diphosphate into the cyclized C15 product than was
the corresponding quantity of mixed unfused enzymes (34).
Efforts in this direction might better regulate recombinant ca-
rotenoid pathways in E. coli, although significant structural in-
formation, which is currently unavailable for carotenoid en-
zymes, may be required.
Specificity by flux balance. Even pathways harboring indi-
vidually promiscuous enzymes can achieve reasonable specific-
ity as a whole if all steps are properly balanced. If the activity
or expression level of each enzyme is properly tuned, produc-
tion of the desired product can be enhanced and the propor-
tion of unwanted side products can be diminished. In addition
to modifying the sequences of promoter or ribosomal binding
sites, Smolke et al. have shown that the individual expression
levels of multiple enzymes can be tuned to some degree by
altering the transcriptional order of the genes in an operon and
varying the stability of mRNA toward nuclease degradation by
using engineered hairpin structures or RNase recognition sites
(189). Although adjusting the expression levels of enzymes
with broad substrate or product specificity is unlikely to elim-
inate undesired metabolites outright, we have observed that
significant increases in the ratio of new to old pathway prod-
ucts can be realized from this approach (unpublished data).
Specificity by diversion of unwanted intermediates. Balanc-
ing enzyme activities or expression levels cannot eliminate side
products if an enzyme converts a single substrate into multiple
products, only one of which is desired. If such enzymes cannot
be engineered to narrow their product range, one strategy for
achieving pathway specificity is to selectively divert unwanted
intermediates away from downstream enzymes in the pathway.
Instead, these intermediates could be catabolized or incorpo-
rated into products that are easily separated from the desired
one(s) by introducing appropriately selective enzymes. In terms
of the conversion yield of precursors into products, this ap-
proach is more wasteful than is engineering enzymes to be
more specific. However, because product recovery costs can
vastly exceed fermentation expenses in industrial processes,
product purity can be more important than product titer (23).
Thus, if a tradeoff is unavoidable, the better choice may be to
accept lower product yield in favor of increased purity.
Prospects and Challenges for Diversifying Other
Pathways by Directed Evolution
Although the best examples of diversifying metabolic path-
ways by directed evolution come from work on the carotenoids,
this approach can be applied to other natural product pathways
as well. There are very good indications that other pathways
and biosynthetic enzymes will be as readily evolvable in the
laboratory as the carotenoid pathways. Jones and Firn hypoth-
esize that many natural product pathways are in fact already
conducting their own combinatorial biosynthesis and high-
throughput screening programs, at least on evolutionary time-
scales (62–64, 91). Because the probability that any particular
small molecule will have potent biological activity is inherently
low, Jones and Firn argue that organisms increase the odds of
discovering new metabolites that provide a selective advantage
by exploring a large number of different structures. Thus, the
argument continues, natural product pathways have evolved
traits that maximize the production and retention of product
diversity while minimizing the costs of synthesizing different
metabolites, most of which are not beneficial to the producer.
Among these traits are branched pathway structures, which
enable the discovery of new metabolites as well as the retention
of existing ones; matrix pathways or metabolic grids, where a
small number of enzymes convert structurally similar precur-
sors to a large number of products by multiple routes; and
promiscuous enzymes, which can accept a variety of substrates
and convert newly discovered metabolites into additional new
products. As we have shown, carotenoid pathways possess
these traits as well as others (e.g., individual enzymes are
evolvable) that can be exploited for forward evolution. On the
other hand, because carotenoids already fulfill important bio-
logical roles and no organism is known to synthesize a large
number of different carotenoids, it is not apparent that nature
is conducting massive searches for new and improved carote-
noids. Other natural product pathways, however, do appear to
be in “search” mode (for example, the bracken fern makes at
least 27 different sesquiterpene indan-1-ones [91]), and these
pathways may be even more evolvable than carotenoid path-
ways.
Isoprenoid pathways are an obvious target for laboratory
evolution. Many isoprenoid biosynthetic enzymes accept a va-
riety of natural and unnatural substrates (91, 139, 140, 147).
The gibberellins, a class of diterpenoid hormones with more
than 120 known members, are synthesized by a metabolic grid
composed of enzymes with broad substrate tolerance (59, 64).
We have shown how the localized specificity of downstream
carotenoid biosynthetic enzymes allowed pathway branches
leading to whole sets of novel compounds to be opened when
the substrate or product preferences of key upstream enzymes
were altered. In a similar example demonstrating the localized
specificity of other isoprenoid biosynthetic enzymes, a mutated
hydroxylase located early in the monoterpene pathway of spear-
mint resulted in a plant with a completely shifted monoterpene
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profile resembling that of peppermint (51). Other isoprenoid
biosynthetic enzymes have very broad product specificity and
synthesize multiple compounds (in one case, more than 50)
from a single substrate (25, 46, 50, 60, 190, 229). Pathways har-
boring such enzymes are therefore highly branched and pro-
vide many possible avenues for further product diversification
by directed evolution of downstream enzymes. Enzymes with
broad specificity, a key feature of evolvable pathways, are found
in the biosynthetic pathways of many other natural products,
including alkaloids, polyketides, shikimate derivatives, nonri-
bosomal peptides, and volatile esters (3, 26, 35, 169, 184, 188).
It is likely that all these pathways will be readily diversified by
laboratory evolution.
Laboratory evolution will also be useful in constructing hy-
brid pathways for new natural products. Nature parsimoniously
achieves great increases in small-molecule product diversity
through the biosynthesis of hybrid natural products. Mycophe-
nolic acid, tocotrienols and tocopherols (vitamin E), canna-
binoids, isoprenoid quinones, furanocoumarins, furanoquino-
lines, alizarin anthraquinones, and certain flavonoids and
alkaloids are examples of natural products formed by the fu-
sion of products from two or more distinct biosynthetic path-
ways (35, 127). Chemical synthesis of unnatural hybrids of
natural products has given rise to molecules with potent bio-
logical activity, many of which possess combined properties of
their individual natural product constituents (reviewed in ref-
erences 132 and 208). The number of possible natural product
hybrids is astronomical, and, like nonhybrid natural products,
most have yet to be made. Accordingly, altering the specificity
of enzymes catalyzing the fusion reactions that lead to hybrid
products in nature may be a promising way to explore natural
product diversity.
While laboratory evolution is likely in principle to be effec-
tive at exploring natural product diversity in a number of path-
ways, in practice, some experiments will be far easier than
others. Thus, the above discussion is not complete without
consideration of the technical issues involved in making and
interrogating large libraries of mutant pathways. The first chal-
lenge is to create and express libraries of mutant enzymes in
the context of a functional pathway. By virtue of their high
transformation efficiency, fast growth, and the large number of
available tools for genetic manipulation, E. coli cells are at-
tractive for laboratory evolution experiments (and many other
metabolic engineering experiments). Also, because E. coli does
not synthesize carotenoids on its own, there is no background
pool of carotenoids to contend with for laboratory evolution or
combinatorial biosynthesis experiments with carotenoid bio-
synthetic pathways. E. coli, however, is not a universal protein
expression machine, nor is it an ideal production host for all
compounds. For example, it lacks the ability to glycosylate
proteins. In addition, the precursors required for the biosyn-
thesis of certain natural products, including many ployketides
and isoprenoids, are present at low levels or not at all in E. coli.
The use of engineered strains of E. coli with increased capacity
for isoprenoid production (reviewed in reference 17) and the
ability to synthesize complex polyketides (reviewed in refer-
ence 161) will overcome this limitation. Alternatively, libraries
can be expressed and even constructed in other organisms
such as Saccharomyces cerevisiae, for which a host of laboratory
evolution tools exist (1, 2, 36, 37, 44, 45). Recently, an ap-
proach to the laboratory evolution of polyketide biosynthesis
was demonstrated in which E. coli was used as a host for
generating a plasmid library by in vivo recombination. This
library was subsequently transformed into a special strain of
Streptomyces venezuelae for expression and screening (99). This
approach combines the ease of genetic manipulation of E. coli
with the ability of Streptomyces to generate bioactive glycosy-
lated polyketides. Many directed enzyme evolution experi-
ments have used an analogous approach in which the mutant
library was generated in E. coli but expressed in another, more
suitable host such as Bacillus subtilis (43, 187, 240). This ap-
proach is then limited by the efficiency of transformation (of-
ten poor, especially for eukaryotic cells) and the ability to
make cell lines that stably and reproducibly express the mutant
sequences (and their pathway products).
Once the library of mutant pathways is constructed and
expressed, it must be screened to identify those that produce a
new or desired metabolite(s). As is the case for directed pro-
tein evolution, this part of the experiment is usually the most
challenging and labor-intensive. In the examples discussed in
this review, it was relatively easy to monitor the characteristic
pigmentation of carotenoids (e.g. using simple, color-based
visual screening of bacterial colonies on plates). It is possible
that color-based screens will similarly prove useful for evolving
flavonoid (195) or porphyrin (114) biosynthetic pathways, since
these products are also pigmented. Nonetheless, most natural
products do not generate fluorescent or UV-visible spectra
that are characteristic and distinguishable in the presence of
cell debris, and other strategies must be employed for screen-
ing. Screening becomes much more challenging when there are
no characteristic spectral changes that can be measured in situ
or when the desired products must be isolated and analyzed
before they can be identified. (Even among visibly colored
families of compounds, new structures are not identifiable by
colony color screening unless their pigmentation differs mark-
edly from that of the products of the native pathway. Addi-
tionally, cell color reflects the total product mixture, and
evolved pathways must therefore generate a significantly dif-
ferent product spectrum from the native pathway in order to
be apparent in a simple color-based screen.) Thus, more gen-
eral methods for rapidly screening microbial clones for the
production of a wide range of natural products are desirable.
Ideally, the screens would require minimal purification or
work-up of cells or lysates, would be highly sensitive and re-
producible, and would be amenable to automation. Mass spec-
trometry (MS) can be used when a target product has a dif-
ferent mass or fragmentation pattern from the product(s) of
the wild-type enzyme(s). Using MS, it is possible to screen up
to 10,000 samples per day (182), and MS screening has been
used to for the directed evolution of enzymes with altered
product profiles or enantioselectivity (166, 168). However, due
to the large capital investment required ($1 million), auto-
mated, high-throughout MS-based screening equipment is
found primarily in well-funded industrial research laboratories.
Screening by high-performance liquid chromatography or thin-
layer chromatography is also feasible but similarly requires
sample pretreatment and is only high-throughout with parallel,
automated instrumentation. Screening using nuclear magnetic
resonance spectroscopy (NMR) has also been demonstrated
(167). Up to 1400 samples per day could be analyzed by an
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NMR spectrometer equipped with a commercially available
flowthrough NMR probe head. Product concentrations, how-
ever, must be quite high for detection by NMR, and pretreat-
ment is required. In some cases, pooling of samples increases
the number of clones that can be screened, provided that there
is sufficient sensitivity to detect the novel compounds (which
are present at a lower concentration). Screens based on bio-
logical properties (e.g., antimicrobial activity or protein bind-
ing), widely used in drug discovery (24, 217, 221), could also be
adapted to laboratory evolution studies.
CONCLUSIONS
In its short history, laboratory pathway evolution has pro-
duced more than 30 carotenoids that have never been seen
in nature. With the ability to make new backbones in E. coli
comes the potential to generate whole families of novel caro-
tenoids through the action of wild-type or laboratory-evolved
carotenoid-modifying enzymes on the new carbon scaffolds.
Applied to other biosynthetic pathways, laboratory pathway
evolution could allow researchers to access thousands of mol-
ecules that are difficult to produce in practical quantities by
synthetic chemistry, are expensive to isolate from natural
sources, or have not been found in nature.
Seeing is believing. Evolving carotenoid biosynthetic path-
ways in the laboratory has allowed us to witness first-hand their
remarkable evolutionary potential. In the process, we have
learned that carotenoid enzymes can acquire new specificities
that allow them to accept different substrates, function in a
foreign pathway, make a different product from the same sub-
strate, and even give rise to new pathways. Furthermore, all of
these changes can be effected in just one round of evolution
and are usually brought about by a single amino acid substi-
tution. As evolution proceeds, we will gain further, detailed
information on how pathways diverge and, we hope, some
elementary understanding of how the stringent specificity of
enzymes and pathways we see in nature is achieved at the
molecular level.
We wonder how far laboratory pathway evolution can be
taken. For example, starting with the genes that make up an
arbitrary biosynthetic pathway in nature, can we evolve any
chemically possible pathway made up of the same basic trans-
formations? We have seen that the carotenoid synthase CrtM
can rapidly acquire new specificities, lose much of its original
function, and yet quickly recover its original function via dif-
ferent mutational routes. This is an encouraging lesson: evolv-
ing an enzyme with narrowed specificity does not “paint it into
a corner,” evolutionarily speaking. It seems that one can abol-
ish a particular specificity with ease but cannot abolish an
enzyme’s inherent ability to evolve. Thus, the enzymes that
exist in 2005 may be perfectly good starting points for creating
widely diverse pathways.
The dramatic functional changes we see in laboratory path-
way evolution experiments remind us that natural product bio-
synthetic pathways are not merely a snapshot of history to be
observed and documented. Rather, these pathways are contin-
ually changing entities whose evolutionary dynamics we are
just beginning to probe. Laboratory evolution experiments
with carotenoid pathways have given us an exciting glance at
these dynamics. Future experiments promise both a greater
understanding of how metabolic systems evolve and the dis-
covery and optimization of biosynthetic routes to a host of
molecules with diverse beneficial impacts on human health and
well-being.
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